Inactive Instrument

Olfactory Biosciences Corp. Share Price Other OTC

Equities

Duration

Period

Style

Olfactory Biosciences Corp. cancelled the transaction announced on May 2, 2017	02/18/02	CI
Olfactory Biosciences Corp. Announces New NOXO Sensory Spectrum Disorders Gel	23/17/23	CI
Olfactory Biosciences Corp. announced that it expects to receive $3 million in funding	02/17/02	CI

15/15/15

Managers	Title	Age	Since
Richard Stevenson CEO	Chief Executive Officer	-	-
Sidney J. Pine DFI	Director of Finance/CFO	-	-
Gregory Van Alfen SAM	Sales & Marketing	-	-

Members of the board	Title	Age	Since
Sidney J. Pine DFI	Director of Finance/CFO	-	-

Sector